54
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Renal Impairment with Clinical Outcomes Following Endovascular Therapy in Acute Basilar Artery Occlusion

, , , , , , & show all
Pages 1017-1028 | Received 02 Feb 2024, Accepted 21 May 2024, Published online: 06 Jun 2024

References

  • El Husseini N, Fonarow GC, Smith EE, et al. Renal dysfunction is associated with poststroke discharge disposition and In-hospital mortality: findings from get with the guidelines-stroke. Stroke. 2017;48:327–334. doi:10.1161/STROKEAHA.116.014601
  • Kelly D, Rothwell PM. Disentangling the multiple links between renal dysfunction and cerebrovascular disease. J Neurol Neurosurg Psychiatry. 2020;91:88–97. doi:10.1136/jnnp-2019-320526
  • Toyoda K, Ninomiya T. Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol. 2014;13:823–833. doi:10.1016/S1474-4422(14)70026-2
  • Arboix A, Massons J, García-Eroles L, Targa C, Oliveres M, Comes E. Clinical predictors of prolonged hospital stay after acute stroke: relevance of medical complications. Int J Clin Med. 2012;3:502–507. doi:10.4236/ijcm.2012.36090
  • Xiao L, Ma M, Gu M, et al. Renal impairment on clinical outcomes following endovascular recanalization. Neurology. 2020;94:e464–e473. doi:10.1212/WNL.0000000000008748
  • Xiao L, Gu M, Lu Y, et al. Influence of renal impairment on clinical outcomes after endovascular recanalization in vertebrobasilar artery occlusions. J Neurointerv Surg. 2021. doi:10.1136/neurintsurg-2021-018003
  • Laible M, Möhlenbruch MA, Pfaff J, et al. Influence of Renal Function on Treatment Results after Stroke Thrombectomy. Cerebrovasc Dis. 2017;44:351–358. doi:10.1159/000481147
  • Carr SJ, Wang X, Olavarria VV, et al. Influence of renal impairment on outcome for thrombolysis-treated acute ischemic stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc analysis. Stroke. 2017;48:2605–2609. doi:10.1161/strokeaha.117.017808
  • Power A, Epstein D, Cohen D, et al. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Cerebrovasc Dis. 2013;35:45–52. doi:10.1159/000345071
  • Mattle HP, Arnold M, Lindsberg PJ, Schonewille WJ, Schroth G. Basilar artery occlusion. Lancet Neurol. 2011;10:1002–1014. doi:10.1016/s1474-4422(11)70229-0
  • Schonewille WJ, Wijman CAC, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724–730. doi:10.1016/s1474-4422(09)70173-5
  • Gory B, Eldesouky I, Sivan-Hoffmann R, et al. Outcomes of stent retriever thrombectomy in basilar artery occlusion: an observational study and systematic review. J Neurol Neurosurg Psychiatry. 2016;87:520–525. doi:10.1136/jnnp-2014-310250
  • Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis. 2005;45:1058–1066. doi:10.1053/j.ajkd.2005.02.028
  • Chelluboina B, Vemuganti R. Chronic kidney disease in the pathogenesis of acute ischemic stroke. J Cereb Blood Flow Metab. 2019;39:1893–1905. doi:10.1177/0271678X19866733
  • Laible M, Jenetzky E, Möhlenbruch MA, et al. Renal Impairment Is Associated with Intracerebral Hemorrhage after Mechanical Thrombectomy in Vertebrobasilar Stroke. Cerebrovasc Dis. 2019;47:48–56. doi:10.1159/000497070
  • Rhim JK, Park JJ, Ahn JH, et al. Influence of renal impairment on neurologic outcomes following mechanical thrombectomy in acute vertebrobasilar stroke. Neuroradiology. 2021. doi:10.1007/s00234-021-02838-0
  • Zi W, Qiu Z, Wu D, et al.; Writing Group for the BG. Assessment of endovascular treatment for acute basilar artery occlusion via a Nationwide Prospective Registry. JAMA Neurol. 2020;77:561–573. doi:10.1001/jamaneurol.2020.0156
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Teo BW, Xu H, Wang D, et al. GFR estimating equations in a multiethnic Asian population. Am J Kidney Dis. 2011;58:56–63. doi:10.1053/j.ajkd.2011.02.393
  • Wang X, Wang Y, Patel UD, et al. Comparison of associations of reduced estimated glomerular filtration rate with stroke outcomes between hypertension and no hypertension. Stroke. 2017;48:1691–1694. doi:10.1161/strokeaha.117.016864
  • Pan Y, Jing J, Chen W, Wang Y, He Y. Association between impaired renal function and stroke outcome in patients with versus without atrial fibrillation. Eur J Neurol. 2018;25:1041–1048. doi:10.1111/ene.13617
  • Saver JL, Gornbein J. Treatment effects for which shift or binary analyses are advantageous in acute stroke trials. Neurology. 2009;72:1310–1315. doi:10.1212/01.wnl.0000341308.73506.b7
  • Ovbiagele B, Schwamm LH, Smith EE, et al. Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease. J Am Heart Assoc. 2014;3:e000905. doi:10.1161/JAHA.114.000905
  • O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200–204. doi:10.1161/01.HYP.0000168052.00426.65
  • Jeon JP, Chen CH, Tsuang FY, et al. Impact of renal impairment on short-term outcomes following endovascular thrombectomy for acute ischemic stroke: a systematic review and meta-analysis. Int J Stroke. 2021:17474930211047337. doi:10.1177/17474930211047337
  • Kelly DM, Ademi Z, Doehner W, et al. Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO Controversies Conference. Stroke. 2021;52:e328–e346. doi:10.1161/strokeaha.120.029680
  • Langezaal LCM, van der Hoeven E, Mont’Alverne FJA, et al. Endovascular therapy for stroke due to Basilar-Artery Occlusion. N Engl J Med. 2021;384:1910–1920. doi:10.1056/NEJMoa2030297
  • Liu X, Dai Q, Ye R, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020;19:115–122. doi:10.1016/S1474-4422(19)30395-3
  • Jovin TG, Li C, Wu L, et al. Trial of thrombectomy 6 to 24 hours after stroke due to Basilar-Artery Occlusion. N Engl J Med. 2022;387:1373–1384. doi:10.1056/NEJMoa2207576
  • Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389:1238–1252. doi:10.1016/S0140-6736(16)32064-5
  • Arboix A, Besses C. Cerebrovascular disease as the initial clinical presentation of haematological disorders. Eur Neurol. 1997;37:207–211. doi:10.1159/000117444
  • Vejakama P, Ingsathit A, McKay GJ, et al. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients. BMC Nephrol. 2017;18:342. doi:10.1186/s12882-017-0753-9
  • Diprose WK, Sutherland LJ, Wang MTM, Barber PA. Contrast-associated acute kidney injury in endovascular thrombectomy patients with and without baseline renal impairment. Stroke. 2019;50:3527–3531. doi:10.1161/strokeaha.119.026738